Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

A groundbreaking study by the Walter and Eliza Hall Institute employs AI to map retinal thickness, unveiling links to ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...

Parapapillary outer temporal retina thickening can reveal diabetic retinopathy development in children with type 1 diabetes mellitus.

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.